                         SEQUENCE LISTING

<110>  The University of Sydney
 
<120>  Treatment of iron disorders

<130>  M50183646

<150>  AU2016905227
<151>  2016-12-16

<160>  17    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  1

Asp Thr His Phe Pro Ile Cys Ile Phe 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Human hepicdin mutant


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  is Asp, Ala, Gly, Ser or Thr

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  is Thr, Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  is His, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  is Phe, Leu, Lys, Ile or Val

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  is Pro, Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  is Ile, Lys, Arg, or His

<400>  2

Xaa Xaa Xaa Xaa Xaa Xaa Cys Ile Phe 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Human hepicdin mutant


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  is Ile, Lys, Arg, or His

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  is Pro, Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  is Phe, Leu, Lys, Ile or Val

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  is His, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  is Thr, Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  is Asp, Ala, Gly, Ser or Thr

<400>  3

Phe Ile Cys Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   


<210>  4
<211>  25
<212>  PRT
<213>  Human hepicdin mutant


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  is Asp, Ala, Gly, Ser or Thr

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  is Thr, Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  is His, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  is Phe, Leu, Lys, Ile or Val

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  is is Pro, Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  is Ile, Lys, Arg, or His

<220>
<221>  MISC_FEATURE
<222>  (15)..(16)
<223>  is a positively charged residue, for example His, Asn, Arg or Lys

<220>
<221>  MISC_FEATURE
<222>  (17)..(18)
<223>  is any amino acid residue

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  is any amino acid residue

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  is a positively charged residue, for example His, Asn, Arg or Lys

<400>  4

Xaa Xaa Xaa Xaa Xaa Xaa Cys Ile Phe Cys Cys Gly Cys Cys Asx Asx 
1               5                   10                  15      


Xaa Xaa Cys Gly Xaa Cys Cys Asx Thr 
            20                  25  


<210>  5
<211>  25
<212>  PRT
<213>  Human hepicdin mutant


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  is Asp, Ala, Gly, Ser or Thr

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  is Thr, Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  is His, Asp or Glu

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  is Phe, Leu, Lys, Ile or Val

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  is Pro, Ala or Gly

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  is Ile, Lys, Arg, or His

<400>  5

Xaa Xaa Xaa Xaa Xaa Xaa Cys Ile Phe Cys Cys Gly Cys Cys His Arg 
1               5                   10                  15      


Ser Lys Cys Gly Met Cys Cys Lys Thr 
            20                  25  


<210>  6
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  6

Ala Thr His Phe Pro Ile Cys Ile Phe 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  7

Asp Ala His Phe Pro Ile Cys Ile Phe 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  8

Asp Thr Asp Phe Pro Ile Cys Ile Phe 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Human hepicdin mutant


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  is Nle

<400>  9

Asp Thr His Xaa Pro Ile Cys Ile Phe 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  10

Asp Thr His Lys Pro Ile Cys Ile Phe 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  11

Asp Thr His Phe Ala Ile Cys Ile Phe 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  12

Asp Thr His Phe Pro Lys Cys Ile Phe 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  13

Ala Thr Asp Phe Pro Ile Cys Ile Phe 
1               5                   


<210>  14
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  14

Ala Thr His Lys Pro Ile Cys Ile Phe 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  15

Asp Thr His Phe Pro Asp Cys Ile Phe 
1               5                   


<210>  16
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  16

Asp Thr His Phe Pro Ile Gly Ile Phe 
1               5                   


<210>  17
<211>  9
<212>  PRT
<213>  Human hepicdin mutant

<400>  17

Asp Thr His Phe Pro Ile Cys Ile Phe 
1               5                   


